The global hemodialysis and peritoneal dialysis market size was estimated at USD 119.49 billion in 2025 and is projected to reach USD 250.38 billion by 2033, growing at a CAGR of 9.84% from 2026 to 2033. The demand for hemodialysis and peritoneal dialysis is driven by several factors, including the rising incidence of acute kidney injury, the scarcity of organ donors, the risks associated with transplants, technological advancements, and initiatives by leading players to introduce advanced products and services.
Any condition with reduced kidney function leads to chronic kidney disease, which may develop into End-Stage Renal Disease (ESRD) over a period. An increase in the prevalence of CKD is expected to boost demand for dialysis products. The rising prevalence of chronic kidney disease is becoming a major global health concern, significantly contributing to the growth of the hemodialysis and peritoneal dialysis market. CKD prevalence is expanding due to the rapid increase in lifestyle-related disorders such as diabetes, hypertension, and obesity, which are the leading causes of kidney damage. Moreover, CKD often progresses silently with minimal symptoms in its early stages, leading to late diagnosis and a higher likelihood of patients advancing to end-stage renal disease (ESRD), where dialysis becomes unavoidable. Improved screening programs and greater awareness are now identifying more cases, thereby expanding the pool of diagnosed patients. Environmental factors, including exposure to toxins and poor water quality in certain regions, are also contributing to the increase in CKD cases.
The growing burden of lifestyle-related diseases is a major factor accelerating the hemodialysis and peritoneal dialysis market, as these conditions are closely linked to kidney damage and eventual renal failure. Diseases such as Diabetes Mellitus and Hypertension are among the leading causes of chronic kidney disease, as prolonged high blood sugar levels and elevated blood pressure gradually impair kidney function over time. The increasing prevalence of obesity, physical inactivity, unhealthy diets, and smoking further exacerbates the risk of kidney complications, leading to a steady rise in CKD cases globally. According to the International Diabetes Federation in 2024, the global burden of Diabetes Mellitus is rapidly increasing, with approximately 589 million adults currently affected, a figure projected to reach 853 million by 2050, and notably, over 4 in 5 (81%) of these individuals residing in low- and middle-income countries.
As more patients with these lifestyle-related conditions progress to advanced stages of kidney disease, the demand for renal replacement therapies such as hemodialysis and peritoneal dialysis increases significantly. In addition, the earlier onset of these diseases in younger populations extends the duration of dialysis dependency, thereby increasing long-term treatment demand. This growing patient pool is driving the expansion of dialysis centers, greater adoption of home-based peritoneal dialysis, and increased use of dialysis consumables and equipment.
The hemodialysis and peritoneal dialysis market is growing due to continuous technological advancements in dialysis equipment, which are improving treatment efficiency, patient comfort, and clinical outcomes. Innovations such as high-flux dialyzers, portable and wearable hemodialysis machines, and automated peritoneal dialysis (APD) systems are making dialysis more convenient and accessible, especially for home-based care. Advanced monitoring features, real-time data tracking, and integration with digital health platforms enable better patient management and reduce complications associated with long-term dialysis. For instance, in 2025, Fresenius Medical Care AG, a leading provider of renal care products and services, is showcasing new research highlighting that hemodiafiltration (HDF) is linked to improved patient outcomes. The company is also emphasizing the role of artificial intelligence (AI) innovations in helping clinicians manage patients more effectively and in a data-driven way.
In addition, the development of biocompatible materials and infection-resistant catheters is enhancing patient safety and reducing the risk of adverse events. These technological improvements are encouraging higher adoption of both hemodialysis and peritoneal dialysis, supporting the shift toward home care settings, and prompting healthcare providers to upgrade existing infrastructure, thereby significantly contributing to market growth.
Any condition with reduced kidney function leads to chronic kidney disease, which may develop into End-Stage Renal Disease (ESRD) over a period. An increase in the prevalence of CKD is expected to boost demand for dialysis products. The rising prevalence of chronic kidney disease is becoming a major global health concern, significantly contributing to the growth of the hemodialysis and peritoneal dialysis market. CKD prevalence is expanding due to the rapid increase in lifestyle-related disorders such as diabetes, hypertension, and obesity, which are the leading causes of kidney damage. Moreover, CKD often progresses silently with minimal symptoms in its early stages, leading to late diagnosis and a higher likelihood of patients advancing to end-stage renal disease (ESRD), where dialysis becomes unavoidable. Improved screening programs and greater awareness are now identifying more cases, thereby expanding the pool of diagnosed patients. Environmental factors, including exposure to toxins and poor water quality in certain regions, are also contributing to the increase in CKD cases.
The growing burden of lifestyle-related diseases is a major factor accelerating the hemodialysis and peritoneal dialysis market, as these conditions are closely linked to kidney damage and eventual renal failure. Diseases such as Diabetes Mellitus and Hypertension are among the leading causes of chronic kidney disease, as prolonged high blood sugar levels and elevated blood pressure gradually impair kidney function over time. The increasing prevalence of obesity, physical inactivity, unhealthy diets, and smoking further exacerbates the risk of kidney complications, leading to a steady rise in CKD cases globally. According to the International Diabetes Federation in 2024, the global burden of Diabetes Mellitus is rapidly increasing, with approximately 589 million adults currently affected, a figure projected to reach 853 million by 2050, and notably, over 4 in 5 (81%) of these individuals residing in low- and middle-income countries.
As more patients with these lifestyle-related conditions progress to advanced stages of kidney disease, the demand for renal replacement therapies such as hemodialysis and peritoneal dialysis increases significantly. In addition, the earlier onset of these diseases in younger populations extends the duration of dialysis dependency, thereby increasing long-term treatment demand. This growing patient pool is driving the expansion of dialysis centers, greater adoption of home-based peritoneal dialysis, and increased use of dialysis consumables and equipment.
The hemodialysis and peritoneal dialysis market is growing due to continuous technological advancements in dialysis equipment, which are improving treatment efficiency, patient comfort, and clinical outcomes. Innovations such as high-flux dialyzers, portable and wearable hemodialysis machines, and automated peritoneal dialysis (APD) systems are making dialysis more convenient and accessible, especially for home-based care. Advanced monitoring features, real-time data tracking, and integration with digital health platforms enable better patient management and reduce complications associated with long-term dialysis. For instance, in 2025, Fresenius Medical Care AG, a leading provider of renal care products and services, is showcasing new research highlighting that hemodiafiltration (HDF) is linked to improved patient outcomes. The company is also emphasizing the role of artificial intelligence (AI) innovations in helping clinicians manage patients more effectively and in a data-driven way.
In addition, the development of biocompatible materials and infection-resistant catheters is enhancing patient safety and reducing the risk of adverse events. These technological improvements are encouraging higher adoption of both hemodialysis and peritoneal dialysis, supporting the shift toward home care settings, and prompting healthcare providers to upgrade existing infrastructure, thereby significantly contributing to market growth.
Global Hemodialysis And Peritoneal Dialysis Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, the analyst has segmented the global hemodialysis and peritoneal dialysis market report based on type, product, end use, and region:Type Outlook (Revenue, USD Million, 2021-2033)
- Hemodialysis
- Conventional hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
- Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
Product Outlook (Revenue, USD Million, 2021-2033)
- Device
- Machine
- Dialyzer
- Water treatment system
- Others
- Consumables
- Bloodline
- Concentrates
- Catheters
- Others
- Service
End Use Outlook (Revenue, USD Million, 2021-2033)
- Home-Based
- Hospital-Based
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Hemodialysis And Peritoneal Dialysis Market Variables, Trends & Scope
Chapter 4. Hemodialysis And Peritoneal Dialysis Market: Type Estimates & Trend Analysis
Chapter 5. Hemodialysis And Peritoneal Dialysis Market: Product Estimates & Trend Analysis
Chapter 6. Hemodialysis And Peritoneal Dialysis Market: End-use Estimates & Trend Analysis
Chapter 7. Hemodialysis And Peritoneal Dialysis Market: Regional Estimates & Trend Analysis, by Type, Product, and End-use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Baxter
- B. Braun SE
- Fresenius Medical Care AG
- Medtronic
- Asahi Kasei Medical Co., Ltd.
- Nipro Corp.
- DaVita (Optum)
- BD
- Nikkiso Co., Ltd.
- Cantel Medical (STERIS plc)
- Diaverum (M42)
- vivISOL
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | May 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 119.49 Billion |
| Forecasted Market Value ( USD | $ 250.38 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
